Skip to main content
. 2009 Sep 8;23(3):188–192. doi: 10.3341/kjo.2009.23.3.188

Fig. 3.

Fig. 3

(A) Iris fluorescein angiogram shows marked dye leakage from rubeotic vessels before intracameral vevacizumab injection. (B) Two weeks after intracameral bevacizumab injection, the leakage from iris neovascularization was remarkably decreased.